Editorial: Utility of protein aggregation assays from laboratory to clinical application
Main Author: | Alison Jane Ellen Green |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2022.998136/full |
Similar Items
-
RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein
by: Ankit Srivastava, et al.
Published: (2022-04-01) -
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
by: Marco J. Russo, et al.
Published: (2021-11-01) -
Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids
by: Nicholas J. Haley, et al.
Published: (2017-08-01) -
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of “Protein-Misfolding Cyclic Amplification” and “Real-Time Quaking-Induced Conversion” as Diagnostic Tools
by: Silvia Paciotti, et al.
Published: (2018-06-01) -
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays
by: Giovanni Bellomo, et al.
Published: (2023-04-01)